Related Experiment Video
Updated: Feb 17, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
"They Call Us Amaphara (Junkies)": Intersectional Tuberculosis, Alcohol, and Drug Stigma in South Africa
Tara Carney1,2,3, Noluthando Mpisane1, Jessica F Magidson4
1Mental Health, Alcohol, Substance Use and Tobacco Research Unit, South African Medical Research Council, Francie Van Zijl Drive, Parow, 7505, Cape Town, South Africa.
Abstract:
Stigma acts as a barrier to the diagnosis and effective treatment of tuberculosis (TB). Individuals with TB who also use alcohol or drugs (AODs), including methamphetamine, may experience intersectional stigma. Further, the nature and intensity of these intersecting stigmas may be compounded by co-morbidities like HIV and marginalized social status. Despite this, AOD use stigma has rarely been studied in the context of TB and other co-occurring conditions. We examined the perceptions and experiences of AOD use-related stigma among individuals who were previously diagnosed with TB or were at increased risk of TB based on their close contacts, in a rural community in the Western Cape, South Africa. We analyzed qualitative data collected by two studies (study 1: five focus groups (n=34), study 2: ten focus groups (n=84)). Findings highlighted that study participants who use AODs experienced intersectional stigma from multiple sources. AOD use- and TB-related stigma were experienced from friends, family, healthcare providers, and the broader community, particularly for those who used illicit drugs. Participants discussed stigma's effects on their health and well-being. The negative effects of AOD use stigma were particularly salient among female participants. Findings indicate that intersecting stigmas exist at multiple levels for people who use AODs with/at risk of TB, and that these stigmas hinder healthcare utilization in this rural setting. Future interventions to improve TB service uptake need to address intersectional AOD use and TB stigma.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Stereotypes, Prejudice, and Discrimination

